StreetAlpha.app
Home › Stocks › HROW

Harrow, Inc. (HROW)

Healthcare
Members
LATEST PRICE

Harrow sells eye care medicines and compounded eye formulations to eyecare doctors and their patients. HROW reports earnings on Mon, Nov 9, 2026.

Prices, price targets and earnings estimates for HROW are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is HROW in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 9
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated HROW in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for HROWThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
Leerink PartnersInitiated
Sep 9Buy
BTIGReiterated
Jul 21Buy
DateFirmActionRatingPrice target
Sep 9Leerink PartnersInitiatedBuy
Jul 21BTIGReiteratedBuy
Loading…

Whale Options Flow

90D

No whale options trades in HROW in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HROW is in one of them and how their past HROW trades turned out.

See how it works→ View all auto pilots→
HROW in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HROW in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About Harrow

Harrow sells eye care medicines, mainly in the United States and Canada. Its branded portfolio includes eye drops and injections for conditions such as dry eye disease, pain after cataract surgery, bacterial eye infections, allergic itching and wet macular degeneration. The company also runs a compounding pharmacy business that supplies custom formulations. Its customers are eyecare doctors, surgeons and their patients. Harrow is based in Nashville, Tennessee.

Headquarters
Nashville, TN
Founded
1998
Summary based on the company’s 2026 annual report (10-K) ↗